A Mendelian randomization study with clinical follow-up links metabolites to risk and severity of pulmonary arterial hypertension (2023)

First Author: Alhathli E

Attributed to: Mechanisms underlying the development of pulmonary arterial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.06.30.23292100

Publication URI: http://dx.doi.org/10.1101/2023.06.30.23292100

Type: Preprint